MA
GILD icon

MCF Advisors’s Gilead Sciences GILD Stock Holding History

MCF Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.72M Buy
21,492
+1,518
+8% +$200K 0.1% 119
2026
Q1 		$2.78M Buy
19,974
+5,311
+36% +$744K 0.12% 95
2025
Q4 		$1.8M Buy
14,663
+5,695
+64% +$692K 0.1% 97
2025
Q3 		$995K Buy
8,968
+2,648
+42% +$301K 0.06% 101
2025
Q2 		$701K Buy
6,320
+29
+0.5% +$3.09K 0.05% 116
2025
Q1 		$705K Sell
6,291
-488
-7% -$50.4K 0.05% 112
2024
Q4 		$626K Buy
6,779
+2,111
+45% +$190K 0.04% 118
2024
Q3 		$391K Sell
4,668
-86
-2% -$6.56K 0.03% 161
2024
Q2 		$326K Sell
4,754
-2,594
-35% -$173K 0.02% 173
2024
Q1 		$538K Buy
7,348
+152
+2% +$11.7K 0.04% 131
2023
Q4 		$583K Buy
7,196
+573
+9% +$44.6K 0.05% 119
2023
Q3 		$496K Buy
6,623
+424
+7% +$32.6K 0.04% 120
2023
Q2 		$478K Sell
6,199
-248
-4% -$19.8K 0.04% 126
2023
Q1 		$535K Buy
6,447
+200
+3% +$16.6K 0.05% 116
2022
Q4 		$536K Buy
6,247
+1,664
+36% +$132K 0.05% 109
2022
Q3 		$283K Buy
4,583
+882
+24% +$55.6K 0.03% 166
2022
Q2 		$229K Sell
3,701
-452
-11% -$28K 0.02% 174
2022
Q1 		$247K Buy
+4,153
New +$265K 0.02% 173
2021
Q4 		– Sell
-2,991
Closed -$209K – 288
2021
Q3 		$209K Buy
2,991
+1,145
+62% +$80.4K 0.02% 178
2021
Q2 		$127K Buy
1,846
+1,539
+501% +$103K 0.01% 212
2021
Q1 		$20K Buy
+307
New +$19.8K ﹤0.01% 365
2016
Q4 		– Sell
-34
Closed -$3K – 450
2016
Q3 		$3K Hold
34
– – ﹤0.01% 399
2016
Q2 		$3K Buy
+34
New +$3.02K ﹤0.01% 433
2015
Q2 		– Sell
-115
Closed -$11K – 440
2015
Q1 		$11K Hold
115
– – ﹤0.01% 316
2014
Q4 		$11K Hold
115
– – ﹤0.01% 299
2014
Q3 		$12K Buy
+115
New +$11.3K ﹤0.01% 302

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MCF Advisors's GILD Position: Q2 2026 in Review

MCF Advisors increased its Gilead Sciences (GILD) stake by 7.6% in Q2 2026, buying an estimated $200K and bringing the position to 21,492 shares worth $2.72M. The position accounts for 0.1% of the portfolio, ranked #119.

MCF Advisors first reported a position in GILD in Q3 2014 and has held it in 26 quarters since. The position peaked at $2.78M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • MCF Advisors held 21,492 shares of Gilead Sciences worth $2.72M as of Q2 2026.
  • MCF Advisors bought 1,518 Gilead Sciences shares in Q2 2026, an estimated $200K.
  • Gilead Sciences made up 0.1% of MCF Advisors's portfolio in Q2 2026, its #119 holding.
  • MCF Advisors first reported a position in Gilead Sciences in Q3 2014 and has held it in 26 quarters since.
  • MCF Advisors's Gilead Sciences position peaked at $2.78M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.